ZNF335
protein-codingzinc finger protein 335, the group of Zinc fingers C2H2-type
Gene summary
The protein encoded by this gene enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. The encoded protein may function by altering local chromatin structure. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~23.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014043
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014043
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014043
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014043
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014043
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZNF335 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022095.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 154 | 8 | 168 | ||
| missense | 2 | 8 | 347 | 37 | 2 | 396 |
| nonsense | 5 | 3 | 1 | 1 | 10 | |
| start loss | 0 | |||||
| frameshift | 7 | 5 | 3 | 15 | ||
| splice donor/acceptor (+/-2bp) | 5 | 6 | 11 | |||
| Total | 14 | 21 | 363 | 192 | 10 | 600 |
Highest pathogenic variant AF is 0.00013074471
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_071378.1 | 27 | MANE Select | |
| Ensembl | ENSP00000325326.2 | 27 | MANE Select | |
| Ensembl | ENSP00000532732.1 | 27 | Standard | |
| Ensembl | ENSP00000532732.1 | 27 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- in utero embryonic development
- positive regulation of neuroblast proliferation
- regulation of transcription by RNA polymerase II
- brain development
- regulation of gene expression
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- RNA polymerase II core promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein binding
- transcription regulatory region DNA binding
Cellular Component
- nucleus
- nucleoplasm
- histone methyltransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000322927
- Coding exons
- 27
- Length
- 23542
- Individuals with no LoFs
- 125637
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 109
- Defined
- 125748
- p
- 0.000441
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.550 | 795 | 840 | 0.947 | 0.0000529 | 8673 |
| Missense (PolyPhen) | 280 | 326.9 | 0.85652 | 3389 | ||
| Synonymous | -0.632 | 360 | 345 | 1.04 | 0.0000228 | 2771 |
| Loss of Function | 4.83 | 23 | 65.0 | 0.354 | 0.00000335 | 710 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00044 | 0.00043 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00054 | 0.00054 | rare |
| Finnish | 0.00043 | 0.00042 | rare |
| European (Non-Finnish) | 0.00055 | 0.00050 | rare |
| South Asian | 0.00030 | 0.00029 | rare |
| Other | 0.0011 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters. Enhances ligand- dependent transcriptional activation by nuclear hormone receptors. Plays an important role in neural progenitor cell proliferation and self-renewal through the regulation of specific genes involved brain development, including REST. Also controls the expression of genes involved in somatic development and regulates, for instance, lymphoblast proliferation. {ECO:0000269|PubMed:12215545, ECO:0000269|PubMed:18180299, ECO:0000269|PubMed:23178126}.;
- Disease
- DISEASE: Microcephaly 10, primary, autosomal recessive (MCPH10) [MIM:615095]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age- related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH10 is characterized by extremely small head size and death usually by 1 year of age. Neuropathologic examination shows severe loss of neurons as well as neuronal loss of polarity and abnormal dendritic maturation. {ECO:0000269|PubMed:23178126}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- LoFtool
- 0.625
- RVIS EVS
- -1.12
- RVIS percentile EVS
- 6.62
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.972
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |